SPECIFIC-INHIBITION OF THE POLYMORPHONUCLEAR LEUKOCYTE CHEMOTACTIC RESPONSE TO HYDROXY-FATTY ACID METABOLITES OF ARACHIDONIC-ACID BY METHYL-ESTER DERIVATIVES

The human polymorphonuclear (PMN) leukocytes chemotactic activity of the hydroxy-fatty acid metabolites of arachidonic acid, 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and 12-L-hydroxy 5,8,10,14-eicosatetraenoic acid (HETE), is eliminated by methylation. Both methyl esters are specific competitive inhibitors of the PMN leukotactic responses to the parent stimuli, and exert no effects on the responses to formyl-methionyl peptides or chemotactic fragments of the fifth component of complement. 50% inhibition of the in vitro chemotactic responses of PMN leukocytes HETE and HHT was achieved by equimolar concentration of the corresponding methyl esters, whereas reciprocal cross-inhibition was observed at molar ratios of HETE methyl ester to HHT and HHT methyl ester to HETE which reflected to the three- to fivefold greater chemotactic potency of HETE relative to HHT. Methyl esters of structurally related, but no chemotactic, fatty acids did not competitively inhibit the chemotaxis elicited by HETE or HHT. The intaperitoneal injection of HETE in guinea pigs evoked an eosinophil response at 30 min and a neutrophil response at 5 h, which were prevented by a one- to twofold molar ratio of HETE methyl ester. The competitive inhibition of the in vitro chemotactic activity and the in vivo leukotactic effect of the unsaturated hydroxy-fatty acids by homologous methyl ester derivatives suggests that the cellular component of natural inflammatory reactions may be susceptible to specific regulation by receptor-directed modulation of the activity of the predominant chemotactic principles.